Attempts to systemically manipulate CLR will need to take potential tumor-promoting off-target effects into account, given the evidence of differing consequences of TLS formation across tissues, the role of TLS in autoimmunity (87), and the contribution of certain CLR-associated chemokines to lymphatic metastasis. Here, DCLK3 is linked to neoplasm.